In 2013 the budger for research and innovation in the EU was 10.84M (source: European Commision) Meanwhile, only in Spain in 2013 the Healthcare expenditure was 92,7M (source: Eurostat)

According to Derek Gatherer, lecturer at Lancaster University, leishmaniasis is among the diseases that are likely to emerge in 2017. This parasitic infection is one of those investigated by DIOMUNE and is best known in Spain for affecting dogs despite the fact that annually in Spain there are about 110 cases  in humans. However, in... Read More

The indiscriminate use of antibiotics has increased exponentially and thus the ability of microbes to become resistant to such antibiotics. As a consequence, antibiotics become increasingly ineffective and ultimately completely useless for the treatment of infectious diseases. The problem is even greater if we consider that in some antimicrobial categories there are few or no... Read More

An epidemiological study conducted at Michigan University shows a decrease of about 2 years in the average age of people having a first stroke and that the incidence rates are actually increasing in the younger age range (people under 55). In DIOMUNE we are working tirelessly to complete the development of our brain stroke treatment with... Read More

Transparency agreement for the use of animals for scientific experimentation in Spain About 90 public and private institutions, among which is Diomune, just signed an agreement on transparency for the use of animals in scientific experimentation in Spain in order to open the doors of laboratories and show how they work and the guarantees and controls research work has... Read More

Spanish innovation is on the hunt for investors at BioSpain 2016 The event took place in Bilbao (Spain) from the 28th to 30th of September.

“Autovaccine against Leishmaniasis using a fluorescent parasite”    

DIOMUNE y Encuentros TEI Bio en Capital Radio

DIOMUNE en laCajabierta